Business Context and Reporting Period
This Form 8-K is filed by Eterna Therapeutics Inc. (trading symbol: ERNA) on December 30, 2024. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with continued listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the company's stock listing.
Material Changes
The material event reported is the receipt of a notice from Nasdaq indicating that the Company's common stock failed to maintain the minimum bid price of $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Contingencies
- Compliance Period: The Company has been granted an initial 180-day compliance period ending June 30, 2025, to regain compliance.
- Regaining Compliance: To cure the deficiency, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days within the compliance period.
- Secondary Compliance: If the Company fails to meet the requirement by June 30, 2025, it may be eligible for a second 180-day period if it meets all other initial listing standards, potentially requiring a reverse stock split.
- Delisting Risk: If the Company cannot cure the deficiency or is deemed ineligible for a second period, Nasdaq may issue a notice of delisting.
- Immediate Impact: The notice has no immediate effect on the listing; the stock will continue to trade under the symbol "ERNA."
Investor Verification Checklist
- Verify the current closing bid price of ERNA stock to assess the likelihood of regaining compliance within the 180-day window.
- Monitor for any announcements regarding a potential reverse stock split to address the bid price deficiency.
- Review the company's cash position and capitalization to determine if a reverse stock split is financially viable.
- Check for subsequent filings confirming whether the 10-day compliance threshold has been met.